Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification

10 Sept 2008

Abstract excerpt

OBJECTIVES: Current treatment guidelines recommend immediate modification of antiretroviral therapy in HIV-infected individuals with incomplete viral suppression. These recommendations have not been tested in observational studies or large randomized trials. We evaluated the consequences of delayed modification following virologic failure. DESIGN/METHODS: We used prospective data from two clinical cohorts to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytomegalovirus and herpesvirus research
Share to HIV Research and Treatment
Share to Immune Cell Function and Interaction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 18784457
DOI: 10.1097/qad.0b013e32830f97e2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modificationPMID 18784457Read ↗

Association Between ART Initiation Timing and Treatment Outcomes in Older People Living With HIV: A Longitudinal Study from Baise, ChinaSemantic proximity Read ↗

The impact of initial highly active antiretroviral therapy on future treatment sequences in HIV infection.Semantic proximity Read ↗

Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection.Semantic proximity Read ↗

Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.Semantic proximity Read ↗

Models of service delivery for optimizing a patient’s first six months on antiretroviral therapy for HIV: an applied research agendaSemantic proximity Read ↗

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART.Semantic proximity Read ↗

Virological Outcomes of Second-line Protease Inhibitor-Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis.Semantic proximity Read ↗

Management of antiretroviral therapy for HIV infection: modelling when to change therapy.Semantic proximity Read ↗

Virological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studySemantic proximity Read ↗

Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study.Semantic proximity Read ↗

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 InfectionSemantic proximity Read ↗

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.